Taichung, Taiwan

Yu-Chiau Shyu

This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Academia Sinica. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yu-Chiau Shyu. Retrieved from https://idiyas.com/inventor/yu-chiau-shyu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 2.4

ph-index = 1


Location History:

  • Taichung, TW (2019 - 2022)
  • Keelung, TW (2022)

Company Filing History:


Years Active: 2019-2026

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations in Cellular Proliferation: The Work of Yu-Chiau Shyu

Introduction

Yu-Chiau Shyu is an accomplished inventor based in Taichung, Taiwan, known for his significant contributions to the field of biomedical research. With a total of three patents to his name, Shyu has demonstrated a remarkable capability in developing innovative methods for enhancing lifespan and combating cellular proliferative disorders. His work primarily focuses on the utilization of genetic engineering and stem cell technology.

Latest Patents

Shyu's latest patents highlight groundbreaking advancements in the treatment of age-related diseases and cancer. One notable patent is focused on "Methods for enhancing lifespan and/or treating cellular proliferative disorders by transplantation." This invention identifies the feasibility of transferring tumor resistance and longevity traits through the transplantation of bone marrow mononuclear cells (BMMNC) or genetically engineered hematopoietic stem cells (HSC). The study further illustrates the expression of the EKLF gene in long-term hematopoietic stem cells (LT-HSC), underscoring its potential as a target for regulating hematopoiesis.

Another patent focuses on an "Animal model of longevity and related methods for increasing longevity and inhibiting tumorigenesis." This invention introduces a genetically modified non-human animal model that promotes longevity and health span while significantly reducing tumorigenesis and metastasis. The related methods aim to identify agents that can enhance longevity and health span, making remarkable strides in cancer research and aging studies.

Career Highlights

Yu-Chiau Shyu is currently affiliated with Academia Sinica, a prestigious research institution in Taiwan known for fostering innovation and advanced scientific research. His work not only contributes to theoretical advancements but also holds potential practical applications in medicine and health care.

Collaborations

Throughout his career, Shyu has collaborated with several distinguished researchers, including Che-Kun James Shen and Chun-Hao Hung. These partnerships have enabled him to further his research objectives and expand the impact of his innovative techniques.

Conclusion

Yu-Chiau Shyu's innovative work in the field of cellular research exemplifies a powerful intersection of genetics and medicine. His patents not only pave the way for new treatment methods for cellular proliferative disorders but also enhance our understanding of aging and longevity. As a trailblazer in his field, Shyu's ongoing research promises to contribute significantly to advancements in health and medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…